Product NewsNew Research Validates Miniaturization of Micronucleus Testing for Genotoxicity by 96-Well Flow Cytometry
Product NewsGentronix Extends Toxicology Screening Services to Include the Detection of Apoptosis Induction
Product NewsRIFM Adopts Gentronix BlueScreen™ HC for Early Genetic Toxicology Screening of Fragrance Materials
Product NewsGentronix Further Expands Early Genotoxicity Screening Capability with Introduction of Ames MPF™ Screening Service
Product NewsADVANCELL partners with Gentronix to Offer Genotoxicity Screening Assays to the Cosmetics and Personal Care Sector
Product NewsGentronix Blue Screen HC Genotoxicity Screening Test Now Available from Charles Rivers Laboratories
Product NewsGentronix Expands Genotoxicity Testing Services with Introduction of in vitro Micronucleus Test
Product NewsGentronix Signs Three Year Agreement with GlaxoSmithKline for GreenScreen HC and BlueScreen HC Genotoxicity Assays
Product NewsGentronix Announces Introduction of its New BlueScreen HC Genotoxicity Assay and an in vitro Comet Testing Service
Product NewsGentronix Presents Further Validation for the High-Throughput Use of Genotoxicity Liability Screen GreenScreen HC at Drug Discovery
Product NewsGentronix presents accurate, high-throughput, genotoxicity liability screening to reduce late-stage attrition in drug development
Product NewsGentronix has launched a human cell-based genotoxicity screening test, called GreenScreen HC, which gives more accurate results than any other currently available in vitro genotoxicity test.
